Similar articles for PMID: 23827346

Year	Number of Results
1992	1
1993	1
1994	3
1995	2
1996	4
1997	4
1998	4
1999	5
2000	7
2001	1
2002	4
2003	5
2004	5
2005	5
2006	3
2007	4
2008	5
2009	3
2010	6
2011	4
2012	4
2013	8
2014	7
2015	3
2016	4
2017	5
2018	2
2019	4
2020	5
2021	8
2022	12
2024	0

1

A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.

Robinson JW, Dickey DM, Miura K, Michigami T, Ozono K, Potter LR. Robinson JW, et al. Bone. 2013 Oct;56(2):375-82. doi: 10.1016/j.bone.2013.06.024. Epub 2013 Jul 1. Bone. 2013. PMID: 23827346 Free PMC article.

2

Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.

Dickey DM, Otto NM, Potter LR. Dickey DM, et al. J Biol Chem. 2017 Jun 16;292(24):10220-10229. doi: 10.1074/jbc.M117.780536. Epub 2017 Apr 27. J Biol Chem. 2017. PMID: 28450398 Free PMC article.

3

The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.

Robinson JW, Lou X, Potter LR. Robinson JW, et al. Br J Pharmacol. 2011 Sep;164(2b):499-506. doi: 10.1111/j.1476-5381.2011.01291.x. Br J Pharmacol. 2011. PMID: 21366551 Free PMC article.

4

Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Potter LR. Potter LR. Pharmacol Ther. 2011 Apr;130(1):71-82. doi: 10.1016/j.pharmthera.2010.12.005. Epub 2010 Dec 24. Pharmacol Ther. 2011. PMID: 21185863 Free PMC article. Review.

5

cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.

Sellitti DF, Puggina E, Lagranha C, Doi SQ. Sellitti DF, et al. J Endocrinol. 2004 Jan;180(1):23-34. doi: 10.1677/joe.0.1800023. J Endocrinol. 2004. PMID: 14709141

6

Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours.

Mirczuk SM, Scudder CJ, Read JE, Crossley VJ, Regan JT, Richardson KM, Simbi B, McArdle CA, Church DB, Fenn J, Kenny PJ, Volk HA, Wheeler-Jones CP, Korbonits M, Niessen SJ, McGonnell IM, Fowkes RC. Mirczuk SM, et al. Int J Mol Sci. 2021 Jan 22;22(3):1076. doi: 10.3390/ijms22031076. Int J Mol Sci. 2021. PMID: 33499110 Free PMC article.

7

Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.

Špiranec K, Chen W, Werner F, Nikolaev VO, Naruke T, Koch F, Werner A, Eder-Negrin P, Diéguez-Hurtado R, Adams RH, Baba HA, Schmidt H, Schuh K, Skryabin BV, Movahedi K, Schweda F, Kuhn M. Špiranec K, et al. Circulation. 2018 Jul 31;138(5):494-508. doi: 10.1161/CIRCULATIONAHA.117.033383. Circulation. 2018. PMID: 29626067

8

Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide).

Chen W, Werner F, Illerhaus A, Knopp T, Völker K, Potapenko T, Hofmann U, Frantz S, Baba HA, Rösch M, Zernecke A, Karbach S, Wenzel P, Kuhn M. Chen W, et al. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):682-696. doi: 10.1161/ATVBAHA.119.313702. Epub 2020 Jan 2. Arterioscler Thromb Vasc Biol. 2020. PMID: 31893950 Free article.

9

Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.

Abbey SE, Potter LR. Abbey SE, et al. Endocrinology. 2003 Jan;144(1):240-6. doi: 10.1210/en.2002-220702. Endocrinology. 2003. PMID: 12488350

10

The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.

Edmund AB, Walseth TF, Levinson NM, Potter LR. Edmund AB, et al. Sci Signal. 2019 Jan 29;12(566):eaau5378. doi: 10.1126/scisignal.aau5378. Sci Signal. 2019. PMID: 30696704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year